Why Big Pharma Ignores Rare Diseases (It’s All About Profits)
The first episode of DeSci Pilled explores the future of decentralized science and its potential to transform biotech and rare disease research. Host Ryan Bethencourt speaks with Ethan Perlstein, a scientist and biotech entrepreneur, about how blockchain, DAOs, and decentralized funding are reshaping medicine.
In this episode, we cover:
- Ethan’s journey from academia to biotech entrepreneurship
- How decentralized science and blockchain are changing research funding
- The rise of Curetopia, the first Solana-native BioDAO
- Why rare diseases are an untapped trillion-dollar market
- The role of IP-NFTs, smart contracts, and crypto in biotech
- How decentralized research can accelerate drug discovery and access to treatments
This is not just another crypto discussion. It’s a deep dive into how we can build a faster, more inclusive, and permissionless future for scientific breakthroughs.
Watch the episode.